NeuroXT
Seoul, Seoul-t'ukpyolsi, South Korea
About NeuroXT
NeuroXT develops software products including NEXT-ATN, NEXT-ALZ-CDx, and NEXT-S.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Jun 2023)
- Website: neuroxt.com
- Phone: +82 010-6236-3295
Industries & Categories
Artificial Intelligence (AI), Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/neuroxt-2583553 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.